Use of health monitor devices to triple by 2020

Adoption of health monitoring devices will nearly triple by 2020, exceeding 70 million worldwide, up from an estimated 26 million this year, according to Juniper Research.

The report, Worldwide Digital Health: Developed and Emerging Market Opportunities 2016-2020, forecasts that FDA approval will drive the rise in use of monitoring devices. However, it highlights the need for new entrants to prove that their hardware is able to measure health indicators with the same accuracy as standard medical devices.

Heightened accuracy from the latest iteration of monitoring devices will lead to a fourfold increase in the number of individuals being monitored by 2020. Interoperability with personal smartphone devices will add further value for the patient, according to the report.

Despite the predicted growth, barriers include the lack of viable business models underpinning the operations in many developing markets.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.